Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Redefining lipodystrophy syndrome: Risks and impact on clinical decision making

Article Abstract:

Multivariate analysis is done to elucidate the relative contribution of risk factors of drug, disease, and host to fat redistribution, large epidemiologic studies in case of lipodystrophy syndrome. The results suggest that impairment to adipocyte differentiation, impairment to adipokine regulation, unopposed production of proinflammatory cytokines, dysregulation of 11-beta-hydroxysteroid dehydrogenase, and mitochondrial toxicity may play a role in diagnosis.

Author: Lichtenstein, Kenneth A.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2005
Analysis, Diagnosis, Multivariate analysis, Fat cells, Adipocytes

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Lipodystrophy and dyslipidemia among patients taking first-line, World Health Organization-recommended highly active antiretroviral therapy regimens in western India

Article Abstract:

The prevalence of lipodystrophy, dyslipidemia, and hyperglycemia among HIV-infected patients taking long term, first-line, World Health Organization (WHO) recommended generic highly active antiretroviral therapy (HAART) regimens in western India is determined. The study demonstrates a high prevalence of morphologic and metabolic complications among patients taking WHO-recommended generic HAART regimens.

Author: Nadler, Jeffrey P., Pujari, Sanjay N., Naik, Eknath, Bhagat, Shobha, Dravid, Ameet, Tash, Kaley, Sinnott, John T.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2005
India, Usage, World Health Organization, Hyperglycemia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi

Article Abstract:

A study conducted to compare measures of adherence to antiretroviral therapy (ART) in HIV-positive adults receiving free treatment from a public hospital in Malawi recommend a requirement of improved methods to detect nonadherence in developing countries and validation of MC data with drug levels and virologic outcome.

Author: Bell, David J., Kapitao, Yamika, Sikwese, Rosemary, van Oosterhout, Joep J., Lalloo, David G.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2007
Malawi, Evaluation, Hospitals, Public, Public hospitals, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Risk factors, Lipodystrophy, Health aspects, Services, HIV infection, Drug therapy, HIV infections, Antiviral agents, Antiretroviral agents
Similar abstracts:
  • Abstracts: Genetic basis of lipodystrophies and management of metabolic complications. HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies
  • Abstracts: Striving for coherence: Psychiatry's efforts over classification. The increasing medical burden in bipolar disorder
  • Abstracts: Lamivudine for patients with chronic hepatitis B and advanced liver disease. Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
  • Abstracts: Erlotinib in lung cancer: Molecular and clinical predictors of outcome. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
  • Abstracts: What to wear for your big break. Getting over myself: How I got over feeling powerless. Ashley Judd's intimate diary
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.